Overview

Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer

Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This trial will assess the intratumoural pharmacological activity of BN83495 by changes in intratumoural levels of sex hormones and associated inhibition of steroid sulphatase (STS) activity.
Phase:
Phase 2
Details
Lead Sponsor:
Ipsen